Healthcare Services

Global Urinary Tract Infection Treatment Industry Trends and Market Growth Forecast for 2026–2030

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Urinary Tract Infection Treatment Market During 2026–2030?

The urinary tract infection treatment market has shown consistent expansion in recent years. It is anticipated to increase from $10.76 billion in 2025 to $11.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.4%. The historical growth in this sector is attributable to the increasing incidence of recurrent UTIs, higher rates of antibiotic prescriptions, better access to primary healthcare, rising public understanding of urinary infections, and the introduction of various antimicrobial drug categories.

The urinary tract infection treatment market is projected to experience consistent expansion in the coming years. This market is anticipated to reach $12.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.8%. Several factors are contributing to this growth during the forecast period, including the increased creation of resistance-aware treatments, rising financial commitments to new antibiotics, the proliferation of swift point-of-care diagnostic tools, an escalating focus on individualized infection management, and the greater uptake of telemedicine for UTI care. Key developments expected within this period involve the increasing use of broad-spectrum antibiotics, a heightened emphasis on rapid diagnostic examinations, a growing need for targeted antimicrobial interventions, the expansion of outpatient options for UTI treatment, and a stronger focus on antimicrobial stewardship.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11958&type=smp

What Underlying Factors Are Accelerating The Growth Of The Urinary Tract Infection Treatment Market?

The increasing occurrence of urinary tract infections is anticipated to propel the growth of the urinary tract infection treatment market. These infections are bacterial and affect parts of the urinary system, including the kidneys, bladder, ureters, and urethra. Treatment for urinary tract infections is crucial for addressing the infection and promoting healing. For instance, data from January 2023, released by the National Institute of Health, a US-based public health research agency, indicated that urinary tract infections were the seventh most common reason for emergency department visits in the USA, amounting to over one million visits annually. Of these, 22% (220,000) were identified as complicated UTIs, and about 100,000 patients are admitted annually. Thus, the rising prevalence of urinary tract infections is a significant driver for the expansion of the urinary tract infection treatment market.

How Are The Various Segments Of The Urinary Tract Infection Treatment Market Categorized?

The urinary tract infection treatment market covered in this report is segmented –

1) By Drug Class: Penicillin And Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides, Azoles And Amphotericin B, Tetracycline, Nitrofurantoin

2) By Indication: Complicated UTI, Uncomplicated UTI

3) By Distribution Channel: Hospital Pharmacies, Gynecology And Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Store

Subsegments:

1) By Penicillin And Combinations: Amoxicillin, Ampicillin, Amoxicillin Or Clavulanate

2) By Quinolones: Ciprofloxacin, Levofloxacin, Norfloxacin

3) By Cephalosporin: Cephalexin, Ceftriaxone, Cefotaxime

4) By Aminoglycoside Antibiotics: Gentamicin, Tobramycin, Amikacin

5) By Sulphonamides: Sulfamethoxazole Or Trimethoprim, Sulfadiazine

6) By Azoles And Amphotericin B: Fluconazole, Itraconazole, Amphotericin B

7) By Tetracycline: Doxycycline, Minocycline

8) By Nitrofurantoin: Nitrofurantoin Monohydrate, Nitrofurantoin Macrocrystals

Which Upcoming Trends Are Expected To Influence The Urinary Tract Infection Treatment Market?

Major companies in the urinary tract infection treatment market are concentrating on launching next-generation therapies, such as pioneering oral antibiotics, to improve patient outcomes and tackle rising antimicrobial resistance. First-in-class oral antibiotics are defined as novel antibacterial agents with unique mechanisms of action designed to treat uncomplicated UTIs caused by common and drug-resistant uropathogens, offering alternatives to existing antibiotics with diminishing effectiveness. For instance, in March 2025, GlaxoSmithKline (GSK), a UK-based biopharmaceutical company, secured approval from the U.S. Food and Drug Administration (FDA) for the antibiotic drug Blujepa (chemical name gepotidacin) for the treatment of uncomplicated urinary tract infections in women and girls aged 12 years and older. Blujepa exhibits a completely novel bacterial topoisomerase-inhibition mechanism, demonstrated efficacy against drug-resistant Escherichia coli, and provides a single-dose oral regimen, signifying a considerable advancement in UTI treatment.

Which Major Firms Influence Developments In The Urinary Tract Infection Treatment Market?

Major companies operating in the urinary tract infection treatment market are Pfizer Inc., Merck & Co Inc, Bayer AG, Sanofi S A, AstraZeneca plc, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddy’s Laboratories Ltd, Cipla Ltd, Hikma Pharmaceuticals PLC, Lupin Limited, Torrent Pharmaceuticals Limited, Glenmark Pharmaceuticals Limited, Mylan N V, Aurobindo Pharma Ltd, Macleods Pharma Ltd, Zydus Cadila Healthcare Ltd, Abbott Laboratories, Shionogi & Co Ltd, Alkem Laboratories Ltd.

Read the full urinary tract infection treatment market report here:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-treatment-global-market-report

Which Region Is Projected To Dominate The Urinary Tract Infection Treatment Market During The Forecast Period?

North America was the largest region in the urinary tract infection treatment market in 2025. The regions covered in the urinary tract infection treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Urinary Tract Infection Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11958&type=smp

Browse Through More Reports Similar to the Global Urinary Tract Infection Treatment Market 2026, By The Business Research Company

Uncomplicated Urinary Tract Infection Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/uncomplicated-urinary-tract-infection-treatment-global-market-report

Chlamydia Infection Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/chlamydia-infection-treatment-global-market-report

Pediatric Bladder Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/pediatric-bladder-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795